Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1988-10-13
1990-04-10
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
423 2, 600 3, 128659, 252625, 252645, A61K 4300, A61B 600, C09K 1104, C01G 5700
Patent
active
049159321
ABSTRACT:
A formulation is provided for the treatment of synovial inflammation, the formulation consisting of dysprosium-165 hydroxide macroaggregates or yttrium-90 hydroxide macroaggregates, wherein the formulation is substantially devoid of other co-precipitating agents in particular, ferric hydroxide. A method of treatment of synovial inflammation is also provided in which the method comprises adminstering an intra-articular injection of the above formulation. Preferably the above formulation is in the form of a isotonic apyrogenic injectable solution.
REFERENCES:
patent: 4752464 (1988-06-01), Lieberman et al.
Sledge, C. B. et al., "Experimental Radiation Synovectomy by DY-165 Ferric Hydroxide Macroaggregate", Arth. & Rhemat, vol. 20, No. 7, (9-10/1977).
Hetherington Eric L.
Maddalena Desmond J.
McLaren Ashley B.
Australian Nuclear Science & Technology Organisation
Maples John S.
LandOfFree
Macroaggregates for radiation synovectomy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macroaggregates for radiation synovectomy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macroaggregates for radiation synovectomy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2298240